FDA Approves Novel Immunotherapy for Advanced Melanoma

The FDA has approved a new immunotherapy treatment for advanced melanoma. This regulatory decision offers an additional therapeutic option for patients with this aggressive skin cancer, potentially improving treatment outcomes.